📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 (2020)

First Author: Gaziano L

Attributed to: Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.19.20234120

Publication URI: http://dx.doi.org/10.1101/2020.11.19.20234120

Type: Preprint